GSK Investigational Site

Springville, Utah 84663

0 studies enrolling now · 2 studies all time

What they study most

Measles, Measles-Mumps-Rubella Vaccine, Mumps, Rubella

Studies at this site

• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life — Completed
• Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age — Completed